Diploma PLC (LON:DPLM – Get Rating) has earned a consensus rating of “Hold” from the seven brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokers that have covered the stock in the last year is GBX 3,170 ($39.08).
DPLM has been the subject of a number of research reports. Barclays reissued an “overweight” rating and set a GBX 3,290 ($40.56) target price on shares of Diploma in a research report on Tuesday, April 12th. Peel Hunt reissued an “add” rating and set a GBX 3,500 ($43.15) target price on shares of Diploma in a research report on Wednesday, January 19th. Royal Bank of Canada raised shares of Diploma to a “sector perform” rating and reduced their target price for the company from GBX 2,600 ($32.05) to GBX 2,450 ($30.20) in a research report on Tuesday. JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of Diploma in a report on Thursday, April 7th. Finally, Shore Capital reaffirmed a “buy” rating on shares of Diploma in a report on Tuesday, April 12th.
DPLM stock traded down GBX 6 ($0.07) during trading on Friday, reaching GBX 2,450 ($30.20). The stock had a trading volume of 417,461 shares, compared to its average volume of 184,544. Diploma has a one year low of GBX 2,354 ($29.02) and a one year high of GBX 3,504 ($43.20). The company has a quick ratio of 0.78, a current ratio of 1.67 and a debt-to-equity ratio of 47.04. The company’s 50 day moving average is GBX 2,675.67 and its two-hundred day moving average is GBX 2,895.64. The company has a market capitalization of £3.05 billion and a price-to-earnings ratio of 44.22.
About Diploma (Get Rating)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.
- The Institutions Are Capping Gains In Take-Two Interactive
- Walmart’s “Everyday Low Prices” Gets Burned By Inflation
- VMWare Inc: Strong Revenues and Excellent Potential
- Beware The Rebound In Home Depot
- Time to Ride These 3 Mid Cap Momentum Plays
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.